Ebovir Biotechnologie Inc. is a Quebec-based biotech focused on the AI-driven research and development of RNA-based therapeutics, mRNA vaccines, and molecular diagnostics targeting infectious diseases and cancer. With our lead R&D platform, Ebo-Pulmo™, we are developing a novel stem-loop RNA innate immune activator designed to stimulate antiviral interferon pathways. In parallel, we are engineering lung-targeted lipid nanoparticles (LNPs) for precise RNA delivery to respiratory tissues. Backed by a dedicated scientific team and proprietary patented technologies, Ebovir is committed to advancing RNA innovation in Quebec and beyond, through active collaboration with academic institutions, clinical centers, and industry partners.
The medical R&D activities of Ebovir Biotechnologie Inc. described above are distinct from the EboScience cosmetic product line. EboScience products are for topical cosmetic use only and are not intended to diagnose, treat, or prevent any medical condition.
